Q2 2026 Holdings
Filed 2026-08-14 | 48 holdings | $541.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $68.8M | 516,447 | 12.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $62.8M | 589,052 | 11.6% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $41.2M | 2,210,852 | 7.6% |
| Brightspring Health Svcs Inc(BTSG) | COM | 10950A106 | $36.1M | 517,315 | 6.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $34.7M | 185,390 | 6.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $27.6M | 29,739 | 5.1% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $23.5M | 448,964 | 4.3% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $19.3M | 339,033 | 3.6% |
| Astrazeneca PLC(AZN) | ORD | G0593M107 | $18.7M | 98,376 | 3.4% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $17.1M | 503,936 | 3.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $15.9M | 162,990 | 2.9% |
| Spdr Series Trust(XBI)Put | ST STR SP BIOT | 78464A870 | $15.8M | 100,000 | 2.9% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $13.8M | 65,122 | 2.5% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $11.4M | 144,376 | 2.1% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $11.0M | 767,098 | 2.0% |
| Alumis Inc(ALMS) | COM | 022307102 | $7.8M | 278,546 | 1.4% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $7.1M | 180,731 | 1.3% |
| Celcuity Inc(CELC) | COM | 15102K100 | $6.2M | 59,316 | 1.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $6.0M | 70,700 | 1.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $6.0M | 46,700 | 1.1% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $5.8M | 138,508 | 1.1% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $5.7M | 22,600 | 1.1% |
| Guardant Health Inc(GH) | COM | 40131M109 | $5.7M | 38,100 | 1.1% |
| Absci Corporation(ABSI) | COM | 00091E109 | $5.4M | 464,444 | 1.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $5.3M | 96,285 | 1.0% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $5.3M | 119,741 | 1.0% |
| Ascendis Pharma A/S(ASND) | ORD SHS | K08588103 | $4.7M | 17,740 | 0.9% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $4.6M | 129,800 | 0.8% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $4.2M | 1,992,367 | 0.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $4.0M | 98,800 | 0.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $4.0M | 18,437 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.9M | 65,000 | 0.7% |
| Belite BIO Inc(BLTE) | SPONSORED ADS | 07782B104 | $3.8M | 24,989 | 0.7% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $3.7M | 137,800 | 0.7% |
| Prokidney Corp(PROK) | SHS CL A | 74291D104 | $3.7M | 1,806,939 | 0.7% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $3.7M | 72,100 | 0.7% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $3.2M | 33,400 | 0.6% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $2.8M | 22,951 | 0.5% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $2.7M | 5,000 | 0.5% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $2.7M | 38,407 | 0.5% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $1.9M | 29,200 | 0.3% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $839.2K | 383,200 | 0.2% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $837.0K | 2,500 | 0.2% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $663.1K | 17,019 | 0.1% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $612.3K | 42,080 | 0.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $605.2K | 4,900 | 0.1% |
| Pepgen Inc(PEPG) | COM | 713317105 | $369.6K | 205,324 | 0.1% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $355.1K | 4,000 | 0.1% |